Brand Name(s): Ceftin; Zinacef
CAS nº: 55268-75-2
(sef yur ox eem)

About Cefuroxime

This new site is dedicated exclusively to cefuroxime, also known by its brand names Ceftin® and Zinacef®.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about cefuroxime on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total cefuroxime experience! 

Why is this medication prescribed?

Cefuroxime is an antibiotic in a class of drugs called cephalosporins. This medicine fights bacteria in the body.

Cefuroxime is used to treat many different types of bacterial infections such as bronchitis, sinusitis, tonsillitis, ear infections, skin infections, gonorrhea, and urinary tract infections.

See more Product Info

Latest News

Orchid receives US FDA approval for Cefuroxime Axetil ANDA

Orchid Chemicals & Pharmaceuticals Ltd on February 20, 2008 has announced that it has received...

[more]

Ranbaxy Receives USFDA Approval For Cefuroxime Axetil

India’s biggest pharma company, Ranbaxy Laboratories Ltd has announced that it has received final...

[more]

Orbus granted European patent for its cefuroxime axetil product compositions

Orbus Pharma Inc. (ORB - TSX), ("Orbus"), today announced that the European Patent Office has...

[more]

Experts debate pros and cons of intracameral cefuroxime

Concerns about the unavailability of cefuroxime in single sterile doses for intracameral injection...

[more]

ORBUS recieves approval and first purchase order for cefuroxime axetil in Spain

Orbus Pharma Inc., today announces it has received regulatory approval for sale in Spain of the...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.